HR 9421 · 119th CongressIn Committeecongress.gov ↗
To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.
Road to The Floor
How it worksIntroduced
In Committee
On The Floor
Passed a Chamber
Passed Congress
To President
Became Law
What this bill does
AI plain-language summaryThis bill would require that any provider approved to prescribe the drug mifepristone must do so only after seeing the patient in person and must hold a medical license in the same state where the patient lives. No official summary is available for this bill.
Introduced
June 24, 2026
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.